Strategic Growth Opportunities in the Convalescent Plasma Therapy Market
The passive immunotherapy industry is experiencing significant transformation as convalescent plasma therapy offers a vital treatment option for infectious diseases. The Convalescent Plasma Therapy Market is valued at USD 1.3 billion in 2024 and projected to reach USD 4.5 billion by 2032 at a CAGR of 16.76%. This article explores strategic growth opportunities emerging across this...
0 Commenti 0 condivisioni 6 Views 0 Anteprima